Devin Morris
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Devin Morris has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Vishwanath Venketaraman
College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, USA
7 shared publications Carlos Guerra
Basic Medical Science Department, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California
4 shared publicationsMelissa Khurasany
4 shared publications- Dennis Gray
From the Department of Anesthesiology, Emory University School of Medicine, Atlanta, Georgia
3 shared publications Frederick Guilford
Your Energy Systems, Palo Alto, California
3 shared publicationsBeatrice Saviola
Basic Medical Science Department, College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, California
2 shared publications
Latest Publications
- 1 May 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1830 (5) , 3329-3349
Glutathione and infection
- 1 May 2013
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1830 (5) , 3329-3349
Glutathione and infection
- 1 May 2013
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 33 (5) , 270-279
Glutathione Supplementation Improves Macrophage Functions in HIV
In this study, we determined the effects of glutathione (GSH)-enhancing agents in restoring the levels of GSH in isolated macrophages from individuals with HIV infection thereby resulting in improved control of Mycobacterium tuberculosis. Our results indicate that treatment with N-acetyl cysteine or a liposomal formulation of glutathione (lGSH) resulted in replenishment of reduced also known as free GSH (rGSH), and correlated with a decrease in the intracellular growth of M. tuberculosis. Finally, we observed differences in the amount of the catalytic subunit of glutamine-cysteine ligase (GCLC), glutathione synthase, and glutathione reductase present in macrophages derived from healthy and HIV-infected individuals. These changes correlated with changes in free radicals as well as rGSH levels. Our results indicate that HIV infection leads to increased production of free radicals and decreased production of GCLC resulting in depletion of rGSH and this may lead, in part, to the loss of innate immune function observed in HIV patients. These findings represent a novel mechanism for control of M. tuberculosis infection, and a possible supplement to current HIV treatments.
- 1 May 2013
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 33 (5) , 270-279
Glutathione Supplementation Improves Macrophage Functions in HIV
In this study, we determined the effects of glutathione (GSH)-enhancing agents in restoring the levels of GSH in isolated macrophages from individuals with HIV infection thereby resulting in improved control of Mycobacterium tuberculosis. Our results indicate that treatment with N-acetyl cysteine or a liposomal formulation of glutathione (lGSH) resulted in replenishment of reduced also known as free GSH (rGSH), and correlated with a decrease in the intracellular growth of M. tuberculosis. Finally, we observed differences in the amount of the catalytic subunit of glutamine-cysteine ligase (GCLC), glutathione synthase, and glutathione reductase present in macrophages derived from healthy and HIV-infected individuals. These changes correlated with changes in free radicals as well as rGSH levels. Our results indicate that HIV infection leads to increased production of free radicals and decreased production of GCLC resulting in depletion of rGSH and this may lead, in part, to the loss of innate immune function observed in HIV patients. These findings represent a novel mechanism for control of M. tuberculosis infection, and a possible supplement to current HIV treatments.
- Open Access
- 1 January 2013
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-11
An Elucidation of Neutrophil Functions againstMycobacterium tuberculosisInfection
We characterized the functions of neutrophils in response toMycobacterium tuberculosis(M. tb) infection, with particular reference to glutathione (GSH). We examined the effects of GSH in improving the ability of neutrophils to control intracellularM. tbinfection. Our findings indicate that increasing the intracellular levels of GSH with a liposomal formulation of GSH (L-GSH) resulted in reduction in the levels of free radicals and increased acidification ofM. tbcontaining phagosomes leading to the inhibition in the growth ofM. tb. This inhibitory mechanism is dependent on the presence of TNF-αand IL-6. Our studies demonstrate a novel regulatory mechanism adapted by the neutrophils to controlM. tbinfection.
- 1 January 2013
- Published by Wiley in Journal of Immunology Research
- Vol. 2013, 1-11
Open AccessAn Elucidation of Neutrophil Functions againstMycobacterium tuberculosisInfection
We characterized the functions of neutrophils in response toMycobacterium tuberculosis(M. tb) infection, with particular reference to glutathione (GSH). We examined the effects of GSH in improving the ability of neutrophils to control intracellularM. tbinfection. Our findings indicate that increasing the intracellular levels of GSH with a liposomal formulation of GSH (L-GSH) resulted in reduction in the levels of free radicals and increased acidification ofM. tbcontaining phagosomes leading to the inhibition in the growth ofM. tb. This inhibitory mechanism is dependent on the presence of TNF-αand IL-6. Our studies demonstrate a novel regulatory mechanism adapted by the neutrophils to controlM. tbinfection.
- Open Access
- 29 December 2011
- Published by Wiley in Journal of Immunology Research
- Vol. 2012, 1-10
Unveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection
We examined the causes for decreased glutathione (GSH) in individuals with HIV infection. We observed lower levels of intracellular GSH in macrophages from individuals with HIV compared to healthy subjects. Further, the GSH composition found in macrophages from HIV+subjects heavily favors oxidized glutathione (GSSG) which lacks antioxidant activity, over free GSH which is responsible for GSH’s antioxidant activity. This decrease correlated with an increase in the growth ofMycobacterium tuberculosis (M. tb)in macrophages from HIV+individuals. In addition, we observed increased levels of free radicals, interleukin-1 (IL-1), interleukin-17 (IL-17) and transforming growth factor-β (TGF-β) in plasma samples derived from HIV+individuals compared to healthy subjects. We observed decreased expression of the genes coding for enzymes responsible for de novo synthesis of GSH in macrophages derived from HIV+subjects using quantitative PCR (qPCR). Our results indicate that overproduction of proinflammatory cytokines in HIV+individuals lead to increased production of free radicals. This combined with the decreased expression of GSH synthesis enzymes leads to a depletion of free GSH and may lead in part to the loss of immune function observed in HIV patients.
- 29 December 2011
- Published by Wiley in Journal of Immunology Research
- Vol. 2012, 1-10
Open AccessUnveiling the Mechanisms for Decreased Glutathione in Individuals with HIV Infection
We examined the causes for decreased glutathione (GSH) in individuals with HIV infection. We observed lower levels of intracellular GSH in macrophages from individuals with HIV compared to healthy subjects. Further, the GSH composition found in macrophages from HIV+subjects heavily favors oxidized glutathione (GSSG) which lacks antioxidant activity, over free GSH which is responsible for GSH’s antioxidant activity. This decrease correlated with an increase in the growth ofMycobacterium tuberculosis (M. tb)in macrophages from HIV+individuals. In addition, we observed increased levels of free radicals, interleukin-1 (IL-1), interleukin-17 (IL-17) and transforming growth factor-β (TGF-β) in plasma samples derived from HIV+individuals compared to healthy subjects. We observed decreased expression of the genes coding for enzymes responsible for de novo synthesis of GSH in macrophages derived from HIV+subjects using quantitative PCR (qPCR). Our results indicate that overproduction of proinflammatory cytokines in HIV+individuals lead to increased production of free radicals. This combined with the decreased expression of GSH synthesis enzymes leads to a depletion of free GSH and may lead in part to the loss of immune function observed in HIV patients.
- Open Access
- 2 December 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (12) , e28378
Glutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
Glutathione (GSH), a tripeptide antioxidant, is essential for cellular homeostasis and plays a vital role in diverse cellular functions. Individuals who are infected with Human immuno deficiency virus (HIV) are known to be susceptible to Mycobacterium tuberculosis (M. tb) infection. We report that by enhancing GSH levels, T-cells are able to inhibit the growth of M. tb inside macrophages. In addition, those GSH-replenished T cell cultures produced increased levels of Interleukin-2 (IL-2), Interleukin-12 (IL-12), and Interferon-gamma (IFN-γ), cytokines, which are known to be crucial for the control of intracellular pathogens. Our study reveals that T lymphocytes that are derived from HIV infected individuals are deficient in GSH, and that this deficiency correlates with decreased levels of Th1 cytokines and enhanced growth of M. tb inside human macrophages.
- 2 December 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (12) , e28378
Open AccessGlutathione and Adaptive Immune Responses against Mycobacterium tuberculosis Infection in Healthy and HIV Infected Individuals
Glutathione (GSH), a tripeptide antioxidant, is essential for cellular homeostasis and plays a vital role in diverse cellular functions. Individuals who are infected with Human immuno deficiency virus (HIV) are known to be susceptible to Mycobacterium tuberculosis (M. tb) infection. We report that by enhancing GSH levels, T-cells are able to inhibit the growth of M. tb inside macrophages. In addition, those GSH-replenished T cell cultures produced increased levels of Interleukin-2 (IL-2), Interleukin-12 (IL-12), and Interferon-gamma (IFN-γ), cytokines, which are known to be crucial for the control of intracellular pathogens. Our study reveals that T lymphocytes that are derived from HIV infected individuals are deficient in GSH, and that this deficiency correlates with decreased levels of Th1 cytokines and enhanced growth of M. tb inside human macrophages.
- Open Access
- 1 November 2010
- Published by Taylor & Francis in International Journal of Interferon, Cytokine and Mediator Research
- Vol. 2, 137-147
Dendritic cells in infectious disease, hypersensitivity, and autoimmunity
Dendritic cells are thought to direct subsequent T lymphocyte-driven adaptive immune responses (Th1/Th2) following interaction with either endogenous or exogenous antigens. These cells have an integral role in the pathogenesis of countless infectious diseases, but their role is most vividly illustrated in human immunodeficiency virus/acquired immunodeficiency syndrome and tuberculosis. Dendritic cells can arise from either myeloid or lymphoid progenitors, but the former is more common. Of particular importance are myeloid-related dendritic cells, plasmacytoid dendritic cells, infiltrating inflammatory dendritic epidermal cells, and Langerhans cells. Myeloid-related dendritic cells resemble typical monocytes, but produce cytokines that favor the cell-mediated immune response. Plasmacytoid dendritic cells resemble plasma cells, but have additional antigen-processing capabilities, and their major role is to produce interferon alpha and beta in response to viral infections. Inflammatory dendritic epidermal cells express the highest concentration of costimulatory molecules known in any cell lineage. Langerhans cells are the chief dendritic cells of the skin, and play a pivotal role in hypersensitivity and autoimmune pathologies, such as atopic dermatitis and psoriasis. Lastly, reduced glutathione has been implicated in modulation of the cytokine profiles of professional antigen-presenting cells, and holds promise as a future immunotherapeutic agent. This review discusses in detail the origin, characteristics, and overall functions of different types of dendritic cells. Furthermore, we have also highlighted the role of dendritic cells in infectious diseases and autoimmune diseases, with special reference to human immunodeficiency virus, tuberculosis, atopic dermatitis, and psoriasis.
- 1 November 2010
- Published by Taylor & Francis in International Journal of Interferon, Cytokine and Mediator Research
- Vol. 2, 137-147
Open AccessDendritic cells in infectious disease, hypersensitivity, and autoimmunity
Dendritic cells are thought to direct subsequent T lymphocyte-driven adaptive immune responses (Th1/Th2) following interaction with either endogenous or exogenous antigens. These cells have an integral role in the pathogenesis of countless infectious diseases, but their role is most vividly illustrated in human immunodeficiency virus/acquired immunodeficiency syndrome and tuberculosis. Dendritic cells can arise from either myeloid or lymphoid progenitors, but the former is more common. Of particular importance are myeloid-related dendritic cells, plasmacytoid dendritic cells, infiltrating inflammatory dendritic epidermal cells, and Langerhans cells. Myeloid-related dendritic cells resemble typical monocytes, but produce cytokines that favor the cell-mediated immune response. Plasmacytoid dendritic cells resemble plasma cells, but have additional antigen-processing capabilities, and their major role is to produce interferon alpha and beta in response to viral infections. Inflammatory dendritic epidermal cells express the highest concentration of costimulatory molecules known in any cell lineage. Langerhans cells are the chief dendritic cells of the skin, and play a pivotal role in hypersensitivity and autoimmune pathologies, such as atopic dermatitis and psoriasis. Lastly, reduced glutathione has been implicated in modulation of the cytokine profiles of professional antigen-presenting cells, and holds promise as a future immunotherapeutic agent. This review discusses in detail the origin, characteristics, and overall functions of different types of dendritic cells. Furthermore, we have also highlighted the role of dendritic cells in infectious diseases and autoimmune diseases, with special reference to human immunodeficiency virus, tuberculosis, atopic dermatitis, and psoriasis.
- Open Access
- 1 October 2010
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. 2, 211-218
Atherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
Atherosclerosis is a leading cause of coronary heart disease and stroke. Since 1981, more than 980,000 cases of AIDS have been reported in the United States. According to the Centers for Disease Control, more than 1 million Americans may be infected with HIV. By killing or damaging CD4+ T cells of the body’s immune system, HIV progressively destroys the body’s ability to fight infections. People diagnosed with AIDS often suffer from life-threatening diseases caused by opportunistic infections such as tuberculosis. HIV-infected individuals have increased risks for atherosclerosis. This review summarizes the effects of oxidized low density lipoproteins in impairing macrophage functions in individuals with atherosclerosis (with and without HIV infection) thereby enhancing the susceptibility to Mycobacterium tuberculosis infection.
- 1 October 2010
- Published by Taylor & Francis in HIV/AIDS - Research and Palliative Care
- Vol. 2, 211-218
Open AccessAtherosclerosis: pathogenesis and increased occurrence in individuals with HIV and Mycobacterium tuberculosis infection
Atherosclerosis is a leading cause of coronary heart disease and stroke. Since 1981, more than 980,000 cases of AIDS have been reported in the United States. According to the Centers for Disease Control, more than 1 million Americans may be infected with HIV. By killing or damaging CD4+ T cells of the body’s immune system, HIV progressively destroys the body’s ability to fight infections. People diagnosed with AIDS often suffer from life-threatening diseases caused by opportunistic infections such as tuberculosis. HIV-infected individuals have increased risks for atherosclerosis. This review summarizes the effects of oxidized low density lipoproteins in impairing macrophage functions in individuals with atherosclerosis (with and without HIV infection) thereby enhancing the susceptibility to Mycobacterium tuberculosis infection.
- 1 June 2006
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 344 (2) , 491-499
Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells
- 1 June 2006
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 344 (2) , 491-499
Calcium-dependent upregulation of E4BP4 expression correlates with glucocorticoid-evoked apoptosis of human leukemic CEM cells